| | | | | December 04, 2011 | New Product Launch - Ellanse Dermal Fillers | | | | | 
Ellansé™ is an exciting new addition to the family of dermal fillers currently available Australia. It is currently the only dermal filler available that bio-stimulates collagen, and has results which last from 12 months to – 3 or 4 years, where most other dermal fillers break down and absorbed by the body within a matter of 6-9 months. Ellanse is different from hyaluronic acid fillers which volumise, whereas Ellanse stimulates the bodies own collagen production and improves the skin’s natural elasticity. Ellanse won the Frost & Sullivan dermal filler of the year award in 2011.
Visit Product Page >
| | | | Related Stories |  | May 17, 2013
Capsule Endoscopy Redefined - Capsule endoscopy has evolved over the last decade to become the first-line noninvasive diagnosis of small-bowel pathologies. [MORE] | | |  | May 14, 2012
Paunches and pot bellies, flabby upper arms, wrinkly knees, loose jowls and localised fat pockets on the body are all areas that have been notoriously difficult to trim and tighten without surgical intervention. [MORE] | | |  | May 14, 2012
Boston, MA April 16, 2012 – BTL Industries announced that its flagship EXILIS RadioFrequency (RF) device was named a 2012 winner by medical aesthetic professionals attending THE Aesthetic Show (TAS). [MORE] | | |  | May 14, 2012
Utrecht, the Netherlands – AQTIS Medical™ BV, is proud to announce that the Ellansé™ dermal filler Family has received market approval for Australia. [MORE] | | |  | March 06, 2012
The CID team has successfully sold and implemented the first McKesson ECG Management system in Australia. [MORE] | | |  | December 14, 2011
Device Technologies is proud of the 8 staff members who undertook the 2011 Eureka Climb to the top of Eureka Tower in Melbourne. [MORE] | | |  | December 04, 2011
Ellansé™ is a Unique Dermal Filler Family which offers a new era of safe and innovative solutions for facial beauty treatments, which are cost-effective by requiring less product for the same indications. [MORE] | | |  | October 19, 2011
Device Technologies continues to expand with the recent acquisition of Advanced Skin Technologies (AST). [MORE] | | |  | October 18, 2011
Introducing the New STERIS SYSTEM 1 Express - The STERIS SYSTEM 1 EXPRESS Sterile Processing System provides high speed turnaround for clean, reusable, immersible, critical and semi-critical devices. [MORE] | | |  | September 21, 2011
The benefits of the STERIS Integration & Digital Connectivity systems is that they offer freedom of choice for customers on which surgical imaging system to use with total “Vendor Neutrality”. [MORE] | | |  | March 08, 2011
In this article, published in Australian Advanced Aesthetics first issue of 2011, Device Technologies Plastic & Aesthetic General Manager, Brett McLachlan, discusses the developments in the industry and the next steps forward for Device Technologies. [MORE] | | |  | March 05, 2013
“Perfect Scars – An exploration of the emotional and physical impact of breast cancer”
is a book of inspiring stories that addresses negative perceptions that often surround breast cancer [MORE] | | |  |
The ride, held in South Africa, sees cancer survivors taking to the open road on motorbikes to rural communities and small towns to raise awareness about early detection, prevention and treatment of especially the shy cancers. [MORE] | | | | Other News Sections | |
 | | |
